Arti Ahluwalia
Keine laufenden Positionen mehr
Karriereverlauf von Arti Ahluwalia
Ehemalige bekannte Positionen von Arti Ahluwalia
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| University of Pisa | Corporate Officer/Principal | - | - |
Tissue Engineering Technologies AG
 Tissue Engineering Technologies AG BiotechnologyHealth Technology Part of Lonza Group AG, Tissue Engineering Technologies AG is a German company that manufactures bacterial and virus vaccines, toxoids, and analogous products. The company is based in Reutlingen City, Germany. The company was founded in 2000 by Hugo Hämmerle. The CEO is Detlef Schumann. | Corporate Officer/Principal | - | - |
Kirkstall Ltd.
 Kirkstall Ltd. Pharmaceuticals: OtherHealth Technology Kirkstall Ltd. provides in vitro cell culture research and the development services. Its products include cancer research, stem cell research, disease modeling, drug discovery and advanced organ models. The company was founded by J. Malcolm Wilkinson, Garry P. Mumford, and Arti Ahluwalia on November 23, 2006 and is headquartered in Rotherham, the United Kingdom. | Technik-/Wissenschafts-/F&E-Leiter | 23.06.2010 | 24.01.2014 |
| Gründer | 23.11.2000 | - |
Statistik
International
| Vereinigtes Königreich | 2 |
| Italien | 2 |
| Deutschland | 2 |
Operativ
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Founder | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Kirkstall Ltd.
Kirkstall Ltd. Pharmaceuticals: OtherHealth Technology Kirkstall Ltd. provides in vitro cell culture research and the development services. Its products include cancer research, stem cell research, disease modeling, drug discovery and advanced organ models. The company was founded by J. Malcolm Wilkinson, Garry P. Mumford, and Arti Ahluwalia on November 23, 2006 and is headquartered in Rotherham, the United Kingdom. | Health Technology |
Tissue Engineering Technologies AG
Tissue Engineering Technologies AG BiotechnologyHealth Technology Part of Lonza Group AG, Tissue Engineering Technologies AG is a German company that manufactures bacterial and virus vaccines, toxoids, and analogous products. The company is based in Reutlingen City, Germany. The company was founded in 2000 by Hugo Hämmerle. The CEO is Detlef Schumann. | Health Technology |
- Börse
- Insiders
- Arti Ahluwalia
- Erfahrung
